Epigenetic regulation of hepatocellular carcinoma progression: MicroRNAs as therapeutic, diagnostic and prognostic factors
The International Journal of Biochemistry & Cell Biology · 2024
DOI: 10.1016/j.biocel.2024.106566 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Biochemistry & Cell Biology, 2024. Verfasst von Mehrdad Hashemi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; Farhikhtegan Medi…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, MicroRNAs, Liver Neoplasms, RNA, Long Noncoding. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 328 Literaturangaben.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC), a significant challenge for public healthcare systems in developed Western countries including the USA, Canada, and the UK, is influenced by different risk factors including hepatitis virus infections, alcoholism, and smoking. The disruption in the balance of microRNAs (miRNAs) plays a vital function in tumorigenesis, given their function as regulators in numerous signaling networks. These miRNAs, which are mature and active in the cytoplasm, work by reducing the expression of target genes through their impact on mRNAs. MiRNAs are particularly significant in HCC as they regulate key aspects of the tumor, like proliferation and invasion. Additionally, during treatment phases such as chemotherapy and radiotherapy, the levels of miRNAs are key determinants. Pre-clinical experiments have demonstrated that altered miRNA expression contributes to HCC development, metastasis, drug resistance, and radio-resistance, highlighting related molecular pathways and processes like MMPs, EMT, apoptosis, and autophagy. Furthermore, the regulatory role of miRNAs in HCC extends beyond their immediate function, as they are also influenced by other epigenetic factors like lncRNAs and circular RNAs (circRNAs), as discussed in recent reviews. Applying these discoveries in predicting the prognosis of HCC could mark a significant advancement in the therapy of this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran…
- Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
- Department of Cellular and Molecular Biology, Nicolaus Copernicus University, Torun, Poland.
- Faculty of medicine, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
- Department of Urologic Sciences and Vancouver Prostate Centre, University of British Columbia, V6H3Z6, Vancouver, BC, Canada.
- UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Zitieren
APA
Hashemi, M., Daneii, P., Asadalizadeh, M., Tabari, K., Matinahmadi, A., Bidoki, S. S., Motlagh, Y. S. M., Jafari, A. M., Ghorbani, A., Dehghanpour, A., Nabavi, N., Tan, S. C., Rashidi, M., Taheriazam, A., Entezari, M., & Goharrizi, M. A. S. B. (2024). Epigenetic regulation of hepatocellular carcinoma progression: MicroRNAs as therapeutic, diagnostic and prognostic factors. The International Journal of Biochemistry & Cell Biology. https://doi.org/10.1016/j.biocel.2024.106566
Vancouver
Hashemi M, Daneii P, Asadalizadeh M, Tabari K, Matinahmadi A, Bidoki SS, et al. Epigenetic regulation of hepatocellular carcinoma progression: MicroRNAs as therapeutic, diagnostic and prognostic factors. The International Journal of Biochemistry & Cell Biology. 2024. doi:10.1016/j.biocel.2024.106566
BibTeX
@article{Hashemi2024,
author = {Hashemi, Mehrdad and Daneii, Pouria and Asadalizadeh, Mahya and Tabari, Kiana and Matinahmadi, Arash and Bidoki, Seyed Shahabadin and Motlagh, Yasamin Sadat Mousavi and Jafari, Ali Moghadas and Ghorbani, Amin and Dehghanpour, Amir and Nabavi, Noushin and Tan, Shing Cheng and Rashidi, Mohsen and Taheriazam, Afshin and Entezari, Maliheh and Goharrizi, Mohammad Ali Sheikh Beig},
title = {Epigenetic regulation of hepatocellular carcinoma progression: MicroRNAs as therapeutic, diagnostic and prognostic factors},
journal = {The International Journal of Biochemistry & Cell Biology},
year = {2024},
doi = {10.1016/j.biocel.2024.106566}
}
EUVIMED